Dr. Reddy's launches —Redyx— COVID-19 drug Remdesivir in India

Dr. Reddys Laboratories Ltd on Wednesday announced the launch of Remdesivir, meant for treatment of COVID-19 patients, under a brand name 'Redyx' in India. According to a press release from the drug maker, the launch is part of the licensing agreement with Gilead Sciences, Inc. (Gilead) that grants Dr Reddys the right to register, manufacture and sell Remdesivir, a potential treatment for Covid-19, in 127 countries including India.

To Contact Insurance and Investment Expert
Thanks for reading. Please Share, Comment, Like the post And Follow, Subscribe Insurance and Investment News
from Source